Venneos

Stuttgart, Germany Founded: 2014 • Age: 12 yrs
Provides a silicon chip-based imaging system for analyzing biological cells.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding $1.1M 2 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Venneos

Venneos is a company based in Stuttgart (Germany) founded in 2014 by David Wehner, Ralf Zeitler, and Jonas Lehmann. It operates as a B2B. Venneos has raised $1.12 million across 2 funding rounds from investors including Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds. Venneos operates in a competitive market with competitors including Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.

  • Headquarter Stuttgart, Germany
  • Founders David Wehner, Ralf Zeitler, Jonas Lehmann
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.12 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    Max-Planck-Gesellschaft

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Venneos

Venneos has successfully raised a total of $1.12M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (10 Sep 2015)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2017 Amount Series A - Venneos Valuation Born2Grow , Max-Planck-Gesellschaft
Sep, 2015 Amount Seed - Venneos Valuation Max-Planck-Gesellschaft , HTGF

Investors in Venneos

Venneos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Max-Planck-Gesellschaft, Born2Grow and High-Tech Gründerfonds.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Born2Grow
-
Founded Year Domain Location
High-Tech Gründerfonds
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
Max-Planck-Gesellschaft
Ombudsman services for scientific misconduct in research are provided confidentially.
Founded Year Domain Location

Investments & Acquisitions by Venneos

Investments

Financial Statements - Venneos

Venneos Comparisons

+
Add Comparison
Available on Premium

Competitors of Venneos

Venneos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mekonos, MicroX Labs, Redbud Labs, Neo Nanotech and Pi Mems, among others.

Company Name Domain Founded year HQ Location Description
Mekonos
domain founded_year HQ Location
Silicon-based nanomachine chips are developed for cell engineering applications.
MicroX Labs
domain founded_year HQ Location
MEMS-based biochips are developed for blood cell counting.
Redbud Labs
domain founded_year HQ Location
Microfluidic platforms for biosensing and sample processing are manufactured.
Neo Nanotech
domain founded_year HQ Location
MEMS-based biochips are manufactured for disease diagnosis and sample processing.
Pi Mems
domain founded_year HQ Location
Titanium-based MEMS devices are developed for microelectronic thermal solutions.

Latest news on Venneos

Frequently Asked Questions about Venneos

Venneos was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Venneos is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.

Venneos is a funded company, having raised a total of $1.12M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.12M, raised on Sep 10, 2015.

Venneos, backed by 1117528.0 from Born2Grow, Max-Planck-Gesellschaft, HTGF, focuses on providing healthcare solutions, advancing biotech innovations, medical imaging, and cell analysis systems. Provides a silicon chip-based imaging system for analyzing biological cells. Driving innovation, growth, and excellence in its industry sectors.

Venneos's top competitors include Mekonos, MicroX Labs and Redbud Labs.

Venneos has 3 investors. Key investors include Max-Planck-Gesellschaft, Born2Grow, and High-Tech Gründerfonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available